Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice

Infection and Immunity

Volumn 68, Issue 5, 2000, Pages 2553-2559

  Carnoy, Christophe ^a,d   Mullet, Chantal ^a   Müller Alouf, Heide ^b   Leteurtre, Emmanuelle ^c   Simonet, Michel ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIV LILLE   (France)

^d INSTITUT DE BIOLOGIE DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGENIC AGENT; SUPERANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; CONTROLLED STUDY; HISTOLOGY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VIRULENCE; YERSINIA PSEUDOTUBERCULOSIS;

EID: 0034019450     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.5.2553-2559.2000     Document Type: Article

References (52)

1. Abe, J., T. Takeda, Y. Watanabe, H. Nakao, N. Kobayashi, D. Y. M. Leung, and T. Kohsaka. 1993. Evidence for superantigen production by Yersinia pseudotuberculosis. J. Immunol. 151:4183-4188.
2. Abe, J., M. Onimaru, S. Matsumoto, S. Noma, K. Baba, Y. Ito, T. Kohsaka, and T. Takeda. 1997. Clinical role for a superantigen in Yersinia pseudotuberculosis infection. J. Clin. Investig. 99:1823-1830.
3. Autenrieth, I. B., M. Beer, E. Bohn, S. H. E. Kaufmann, and J. Heesemann. 1994. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect. Immun. 62:2590-2599.
4. Baba, K., N. Takeda, and M. Tanaka. 1991. Cases of Yersinia pseudotuberculosis infection having diagnostic criteria of Kawasaki disease. Contrib. Microbiol. Immunol. 12:292-296.
5. Blank, C., A. Luz, S. Bendigs, A. Erdmann, H. Wagner, and K. Heeg. 1997. Superantigen and endotoxin synergize in the induction of lethal shock. Eur. J. Immunol. 27:825-833.
6. Bliska, J. B., K. L. Guan, J. E. Dixon, S. Falkow. 1991. Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc. Natl. Acad. Sci. USA 88:1187-1191.
7. Blomfield, I. C., V. Vaughn, R. F. Rest, and B. I. Eisenstein. 1991. Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon. Mol. Microbiol. 5:1447-1457.
8. Bölin, I., and H. Wolf-Watz. 1988. The plasmid-encoded Yop2b protein of Yersinia pseudotuberculosis is a virulence determinant regulated by calcium and temperature at the level of transcription. Mol. Microbiol. 2:237-245.
9. Bonventre, P. F., H. Heeg, C. Cullen, and C.-J. Lian. 1993. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect. Immun. 61:793-799.
10. Butler, T. 1983. Plague and other Yersinia infection. Plenum Press, New York, N.Y.
11. Carnoy, C., and S. L. Moseley. 1997. Mutational analysis of receptor binding mediated by the Dr family of Escherichia coli adhesins. Mol. Microbiol. 23:365-379.
12. Carnoy, C., H. Müller-Alouf, S. Haentjens, and M. Simonet. 1998. Polymorphism of ypm, Yersinia pseudotuberculosis superantigen encoding gene. Zentbl. Bakteriol. Suppl. 29:397-398.
13. Carnoy, C., and M. Simonet. 1999. Yersinia pseudotuberculosis superantigenic toxins, p. 611-622. In J. E. Alouf and J. H. Freer (ed.), The comprehensive source book of bacterial protein toxins, 2nd ed. Academic Press, London, England.
14. Cornelis, G. R., A. Boland, A. P. Boyd, C. Geuijen, M. Iriarte, C. Neyt, M.-P. Sory, and I. Stainier. 1998. The virulence plasmid of Yersinia, an antihost genome. Microbiol. Mol. Biol. Rev. 62:1315-1352.
15. de Almeida, A. M. P., A. Guiyoule, I. Guilvout, I. Iteman, G. Baranton, and E. Carniel. 1993. Chromosomal irp2 gene in Yersinia: distribution, expression, deletion and impact on virulence. Microb. Pathog. 14:9-21.
16. Donnelly, G. A. E., J. Lu, T. Takeda, and D. M. McKay. 1999. Colonic epithelial physiology is altered in response to the bacterial superantigen Yersinia pseudotuberculosis mitogen. J. Infect. Dis. 180:1590-1596.
17. Donnenberg, M. S., and J. B. Kaper. 1991. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect. Immun. 59:4310-4317.
18. Donnenberg, M. S., J. Yu, and J. B. Kaper. 1993. A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells. J. Bacteriol. 175:4670-4680.
19. Guiney, D. G. 1997. Regulation of bacterial virulence gene expression by the host environment. J. Clin. Investig. 4:565-569.
20. Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580.
21. Hancock, G. E., R. W. Schaedler, and T. T. MacDonald. 1986. Yersinia enterocolitica infection in resistant and susceptible strains of mice. Infect. Immun. 53:26-31.
22. Heesemann, J., K. Gaede, and I. B. Autenrieth. 1993. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS 101:417-429.
23. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
24. Ito, Y., J. Abe, K.-I. Yoshino, T. Takeda, and T. Kohsaka. 1995. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein. J. Immunol. 154: 5896-5906.
25. Konishi, N., K. Baba, J. Abe, T. Maruko, K. Waki, N. Takeda, and M. Tanaka. 1997. A case of Kawasaki disease with coronary artery aneurysms documenting Yersinia pseudotuberculosis infection. Acta Paediatr. 86:661-664.
26. Ljungberg, P., M. Valtonen, V. P. Harjola, S. S. Kaukoranta-Tolvanen, and M. Vaara. 1995. Report of four cases of Yersinia pseudotuberculosis septicemia and a literature review. Eur. J. Clin. Microbiol. Infect. Dis. 14:804-810.
27. Marmur, J. 1961. A procedure for the isolation of desoxyribonucleic acid from microorganisms. J. Mol. Biol. 3:208-218.
28. Mekalanos, J. J. 1992. Environmental signals controlling expression of virulence determinants in bacteria. J. Bacteriol. 174:1-7.
29. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170:2575-2583.
30. Miyoshi-Akiyama, T., K. Imanischi, and T. Uchiyama. 1993. Purification and partial characterization of a product from Yersinia pseudotuberculosis with the ability to activate human T cells. Infect. Immun. 61:3922-3927.
31. Miyoshi-Akiyama, T., A. Abe, H. Kato, K. Kawahara, H. Narimatsu, and T. Uchiyama. 1995. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM. J. Immunol. 154:5228-5234.
32. Miyoshi-Akiyama, T., W. Fujimaki, X. J. Yan, J. Yagi, K. Imanishi, H. Kato, K. Tomonari, and T. Uchiyama. 1997. Identification of murine T cells reactive with the bacterial superantigen Yersinia pseudotuberculosis-derived mitogen (YPM) and factors involved in YPM-induced toxicity in mice. Microbiol. Immunol. 41:345-352.
33. Monack, D. M., J. Mecsas, D. Bouley, and S. Falkow. 1998. Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J. Exp. Med. 188:2127-2137.
34. Müller-Alouf, H., C. Geoffroy, P. Geslin, A. Bouvet, A. Felten, E. Günther, J.-H. Ozegowski, and J. E. Alouf. 1997. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections. Zentbl. Bakteriol. 286:421-433.
35. Nakano, T., H. Kawaguchi, K. Nakao, T. Maruyama, H. Kamiya, and M. Sakurai. 1989. Two outbreaks of Yersinia pseudotuberculosis 5a infection in Japan. Scand. J. Infect. Dis. 21:175-179.
36. Ramamurthy, T., K.-I. Yoshino, J. Abe, N. Ikeda, and T. Takeda. 1997. Purification, characterization and cloning of a novel variant of the superantigen Yersinia pseudotuberculosis-derived mitogen. FEBS Lett. 413:174-176.
37. Riot, B., P. Berche, and M. Simonet. 1997. Urease is not involved in the virulence of Yersinia pseudotuberculosis in mice. Infect. Immun. 65:1985-1990.
38. Rott, O., and B. Fleischer. 1994. A superantigen as virulence factor in an acute bacterial infection. J. Infect. Dis. 169:1142-1146.
39. Sato, K., K. Ouchi, and M. Taki. 1983. Yersinia pseudotuberculosis infection in children, resembling Izumi fever and Kawasaki syndrome. Pediatr. Infect. Dis. 2:123-126.
40. Simon, R., U. Priefer, and A. Pühler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Bio/Technology 1:784-791.
41. Simonet, M., S. Richard, and P. Berche. 1990. Electron microscopic evidence for in vivo extracellular localization of Yersinia pseudotuberculosis harboring the pYV plasmid Infect. Immun. 58:841-845.
42. Simonet, M., N. Fortineau, J. L. Beretti, and P. Berche. 1994. Immunization with live aroA recombinant Salmonella typhimurium producing invasin inhibits intestinal translocation of Yersinia pseudotuberculosis. Infect. Immun. 62:863-867.
43. Stiles, B. G., S. Bavari, T. Krakauer, and R. G. Ulrich. 1993. Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect. Immun. 61:5333-5338.
44. Stock, J. B., A. M. Stock, and J. M. Mottonen. 1990. Signal transduction in bacteria. Nature 344:395-400.
45. Tertti, R., K. Granfors, O.-P. Lehtonen, J. Mertsola, A.-L. Mäkelä, I. Välimäki, P. Hänninen, and A. Toivanen. 1984. An outbreak of Yersinia pseudotuberculosis infection. J. Infect. Dis. 149:245-250.
46. Tertti, R., R. Vuento, P. Mikkola, K. Granfors, A.-L. Mäkelä, and A. Toivanen. 1989. Clinical manifestations of Yersinia pseudotuberculosis infection in children. Eur. J. Clin. Microbiol. Infect. Dis. 8:587-591.
47. Trieu-Cuot, P., and P. Courvalin. 1983. Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3′5″-aminoglycoside phosphotransferase type III. Gene 23:331-341.
48. Uchiyama, T., T. Miyoshi-Akiyama, H. Kato, W. Fujimaki, K. Imanishi, and X.-J. Yan. 1993. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J. Immunol. 151:4407-4413.
49. Ueshiba, H., H. Kato, T. Miyoshi-Akiyama, M. Tsubokura, T. Nagano, S. Kaneko, and T. Uchiyama. 1998. Analysis of the superantigen-producing ability of Yersinia pseudotuberculosis strains of various serotypes isolated from patients with systemic or gastroenteric infections, wildlife animals and natural environments. Zentbl. Bakteriol. 288:277-291.
50. Vieira, J., and J. Messing. 1982. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19:259-268.
51. Yoshino, K.-I., J. Abe, H. Murata, T. Takao, T. Kohsaka, Y. Shimonishi, and T. Takeda. 1994. Purification and characterization of a novel superantigen produced by a clinical isolate of Yersinia pseudotuberculosis. FEBS Lett. 356:141-144.
52. Yoshino, K.-I., T. Ramamurthy, G. B. Nair, H. Fukushima, Y. Ohtomo, N. Takeda, S. Kaneko, and T. Takeda. 1995. Geographical heterogeneity between Far East and Europe in prevalence of ypm gene encoding the novel superantigen among Yersinia pseudotuberculosis strains. J. Clin. Microbiol. 33:3356-3358.